2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with isoflurophate in 1 studies
Studies (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Trials (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Recent Studies (post-2010) (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Studies (isoflurophate) | Trials (isoflurophate) | Recent Studies (post-2010) (isoflurophate) |
---|---|---|---|---|---|
31 | 0 | 6 | 3,337 | 1 | 123 |
Protein | Taxonomy | 2'-cyano-2'-deoxyarabinofuranosylcytosine (IC50) | isoflurophate (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.48 | |
Lysosomal protective protein | Homo sapiens (human) | 10 | |
Fatty acid synthase | Rattus norvegicus (Norway rat) | 0.05 | |
Acetylcholinesterase | Homo sapiens (human) | 0.12 | |
Liver carboxylesterase | Sus scrofa (pig) | 0.05 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eshima, K; Fukushima, M; Iizuka, K; Jin, C; Zhang, C | 1 |
1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and isoflurophate
Article | Year |
---|---|
Analysis of the prolonged infusion of DFP-10917, a deoxycytidine analog, as a therapeutic strategy for the treatment of human tumor xenografts in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Deoxycytidine; DNA Breaks, Double-Stranded; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; G2 Phase Cell Cycle Checkpoints; Gemcitabine; Humans; Infusions, Intravenous; Isoflurophate; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Neoplasms; Paclitaxel; Xenograft Model Antitumor Assays | 2018 |